BG
DRNA

Bellevue Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bellevue Group’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-61,000
Closed -$2.28M – 225
2021
Q2 		$2.28M Sell
61,000
-7,000
-10% -$261K 0.02% 140
2021
Q1 		$1.74M Hold
68,000
– – 0.02% 144
2020
Q4 		$1.5M Buy
+68,000
New +$1.5M 0.02% 149